Progesterone Receptor-positive Breast Cancer
📧 Sign up to get email alerts when something new happens for Progesterone Receptor-positive Breast Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Testing the Addition of an Anti-cancer Drug, Berzosertib, to the Usual Treatment (Radiation Therapy) for Chemotherapy-Resistant Triple-Negative and Estrogen and/or Progesterone Receptor Positive, HER2 Negative Breast Cancer [Phase 1]
This clinical trial update reports testing the addition of berzosertib to radiation therapy in patients with chemotherapy-resistant triple-n…
-
CLINICAL_TRIALS research · 2026-04-08Clinical Trial Update: Trial of Pre-operative Neratinib and Endocrine Therapy With Trastuzumab in ER-Positive, HER-2 Positive Breast Cancers [Phase 2]
Phase 2 clinical trial evaluating pre-operative Neratinib and Trastuzumab with endocrine therapy for ER-positive, HER2-positive breast cance…
-
CLINICAL_TRIALS research · 2026-03-30Clinical Trial Update: Enhancing Skin Appearance and Quality of Life in Breast Cancer Survivors on Aromatase Inhibitor Therapy
A Mayo Clinic-sponsored trial is evaluating interventions to improve skin appearance and quality of life for breast cancer survivors on arom…
-
CLINICAL_TRIALS research · 2024-07-23Clinical Trial Update: BYL719 and Letrozole in Post-Menopausal Patients With Hormone Receptor-Positive Metastatic Breast Cancer [Phase 1]
Phase 1 clinical trial evaluating BYL719 (alpelisib) with letrozole in post-menopausal women with hormone receptor-positive metastatic breas…